Please login to the form below

Not currently logged in


This page shows the latest Immunology news and features for those working in and with pharma, biotech and healthcare.

BMS and Celgene announce $74bn merger

BMS and Celgene announce $74bn merger

He says the combined company will be able to enhance its positions across the portfolio, including in the most lucrative but also intensely competitive cancer and immunology and inflammation therapy areas. ... It also TYK2 and ozanimod in immunology and

Latest news

More from news
Approximately 7 fully matching, plus 170 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    None of the other biosimilars in the agreement between the two companies, in the fields of oncology and immunology, are affected.

  • Tackling a formidable foe Tackling a formidable foe

    Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck. ... Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck, epitomises the field’s passion and refusal to take a

  • Deal Watch January 2018

    Back in June 2015 Celgene and Juno announced a ten-year collaboration to combine their respective immunology expertise to develop new immunotherapies for cancer and autoimmune diseases based on T cell

  • The good, the bad and the ugly The good, the bad and the ugly

    selling drug until its patent expiry in the US in 2023,” says Alexandra Annis, senior analyst, immunology, GlobalData. ... The immunology market has seen setbacks too, with sales at both Pfizer (-3.6%) and Amgen (-10.8%) notably declining.

  • Digital disruption Digital disruption

    Clearly these aren’t isolated examples. Pfizer has teamed up with IBM to accelerate its search for immunology treatments, hoping to identify new drug treatments.

More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...